the leaflet component was deployed using a flexible delivery system to the
central section of the posterior
article focused on the
central mechanisms of action of 2-[3-methyl-7-(thietan-3-yl)-1-ethylxanth-7-ylthio
Bikbova, M.M.,
Usubova, E.L.,
Oganisyana, K.Kh.,
Lobov, S.L.,
Khasanovad, R.R.,
Dzhemilevab, L.U.,
Khusnutdinova, E.K. (2017) , the association of
central corneal thickness (CCT) with a number of genetic loci is revealed.
Thus, diverse
Zaplakhova, O. V.,
Nasibullin, T. R.,
Tuktarova, I. A.,
Timasheva, Y. R.,
Erdman, V. V.,
Bakhtiyarova, K. Z.,
Mustafina, O. E. (2018) is the result of autoimmune and neurodegenerative processes which lead to multifocal lesions of the
centralBeylerli, O.A.,
Azizova, S.T.,
Konovalov, N.A.,
Akhmedov, A.D.,
Gareev, I.F.,
Belogurov, A.A. (2020) in the tissues of
central nervous system and may be crucial in the pathogenesis of certain diseases of nervous
Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) for treating PSF. Methods: We screened Airitri, CNKI, VIP, CINAHL, ClinicalTrials.gov,
CENTRAL, Cochrane Stroke
Beylerli, Ozal,
Beilerli, Aferin,
Ilyasova, Tatiana,
Shumadalova, Alina,
Shi, Huaizhang,
Sufianov, Albert (2024) . This intriguing finding raises the possibility that circRNAs may have a
central role in the initiation
Zivari-Ghader, Tayebeh,
Valioglu, Ferzane,
Eftekhari, Aziz,
Aliyeva, Immi,
Beylerli, Ozal,
Davran, Soodabeh,
Cho, William C.,
Beilerli, Aferin,
Khalilov, Rovshan,
Javadov, Sabzali (2024) of conventional treatments for patients with
central nervous system diseases. The blood-brain barrier prevents
Jiang, Jianhao,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2024) (HSCs) play a
central role. Recent strides in scientific exploration have unveiled the intricate
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively target various structures within the
central nervous system (CNS). MiRNA-based therapy stands out